Allergy Therapeutics PLC Holding(s) in Company (6667D)
January 30 2015 - 10:58AM
UK Regulatory
TIDMAGY
RNS Number : 6667D
Allergy Therapeutics PLC
30 January 2015
For filings with the FCA include
the annex
For filings with issuer exclude
the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i)
1. Identity of the issuer or the Allergy Therapeutics PLC
underlying issuer of existing shares
to which voting rights are attached:
(ii)
2 Reason for the notification (please tick the appropriate box
or boxes):
An acquisition or disposal of voting rights X
------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already
issued to which voting rights are attached
------
An acquisition or disposal of instruments with similar
economic effect to qualifying financial instruments
------
An event changing the breakdown of voting rights
------
Other (please
specify):
----------------- ---------------------------------------------- ------
3. Full name of person(s) subject SOUTHERN FOX INVESTMENTS LTD.
to the notification obligation:
(iii)
4. Full name of shareholder(s) CHASE NOMINEES LTD -CMBLJPPB
(if different from 3.): (iv)
------------------------------
5. Date of the transaction and date 23(rd) January, 2015
on which the threshold is crossed
or reached: (v)
------------------------------
6. Date on which issuer notified: 30(th) January, 2015
------------------------------
7. Threshold(s) that is/are crossed Over 27.21%
or
reached: (vi, vii)
------------------------------
8. Notified details:
A: Voting rights attached to shares (viii, ix)
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------------------- -----------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights (x)
Shares Voting
Rights
------------ ------------ ------------ ----------------------- --------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------ ------------ ------------ ------------ --------- --------- ---------
Ord GBP 0.01
GB00B02LCQ05 108,512,784 108,512,784 111,589,283 111,589,283 27.21%
------------ ------------ ------------ ------------ --------- --------- ---------
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion rights that rights
Period (xiv) may be
acquired if
the
instrument is
exercised/ converted.
------------- -------------- ----------------------- ------------
C: Financial Instruments with similar economic effect to Qualifying
Financial Instruments (xv, xvi)
Resulting situation after the triggering transaction
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
--------- ----------- ------------ ------------------- ----------------
Nominal Delta
--------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
Number of voting rights Percentage of voting rights
----------------------------
111,589,283 27.21%
----------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: (xxi)
Proxy Voting:
10. Name of the proxy holder: SOUTHERN FOX INVESTMENTS
LTD
--------------------------
11. Number of voting rights proxy
holder will cease to hold:
--------------------------
12. Date on which proxy holder will
cease to hold voting rights:
--------------------------
13. Additional information:
14. Contact name: George O' Carroll
-------------------
15. Contact telephone number: +353-61-472019
-------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLURVVRVBAAOAR
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Apr 2023 to Apr 2024
